Expert insights. Personalized for you.
Bio Pharma Dive
DECEMBER 6, 2022
The second startup to emerge from Star’s “hub-and-spoke” model aims to develop a Hemlibra-like antibody drug for the blood clotting disorder von Willebrand disease
The FDA Law Blog
DECEMBER 5, 2022
By Douglas B. Farquhar & John W.M.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
DECEMBER 5, 2022
After a private equity takeover unraveled this summer, the women’s health company is selling its drug portfolio to Mayne Pharma in a $153 million deal
Intouch Solutions
DECEMBER 1, 2022
Finding an agency job after graduating college can feel overwhelming, but it doesn’t have to. Jumpstart your career at EVERSANA INTOUCH and be set up for success as part of our Account Incubator program where you can dip your toes into an Account Services role!
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Pharma Phorum
DECEMBER 4, 2022
Clinical trials of a wireless brain chip developed by Elon Muck’s Neuralink company will be tested in human volunteers within the next six months – and Musk himself says he intends to have one implanted for a future demo event.
The Pharma Data
DECEMBER 2, 2022
The European Commission and WHO extend their strategic cooperation to deliver better health for all.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Fierce Pharma
DECEMBER 7, 2022
GSK, Sanofi, Pfizer and Boehringer Ingelheim free from federal Zantac litigation with new ruling. zbecker. Wed, 12/07/2022 - 10:05
BioPharma Reporter
DECEMBER 6, 2022
Global pharma giants, GSK, Sanofi, and Takeda, are set to collaborate with Singapore researchers to boost innovation in local biologics and vaccines manufacturing. Markets & Regulations
Pharma Phorum
DECEMBER 6, 2022
Clinical trials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck in the past.
The Pharma Data
DECEMBER 6, 2022
Novartis Kisqali® prolonged PFS benefit for pre- and perimenopausal patients with aggressive HR+/HER2− metastatic breast cancer compared to chemotherapy. Novartis.
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
Fierce Pharma
DECEMBER 2, 2022
With buyout on Horizon, Amgen and Sanofi eye cash plays for rare disease drug maker. fkansteiner. Fri, 12/02/2022 - 09:51
BioSpace
DECEMBER 4, 2022
Whether a job search is voluntary or not, the psychological toll of months of interviews, wrangling over pay and benefits and evaluating options has a weighty psychological toll
Pharmaceutical Technology
DECEMBER 5, 2022
Sanofi has signed an agreement with the Queensland Government in Australia to establish a $190m (A$280m) research facility in Brisbane. With the establishment of this Translational Science Hub, Queensland is set to become an international messenger ribonucleic acid (mRNA) vaccine hub.
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
Bio Pharma Dive
DECEMBER 5, 2022
The positive results could help Novartis secure approval for earlier use of the radiopharmaceutical drug Pluvicto, potentially broadening the number of eligible patients by several times the current market
Fierce Pharma
DECEMBER 1, 2022
With FDA nod for its fecal microbiome therapy, Ferring becomes No. 1 in No. kdunleavy. Thu, 12/01/2022 - 10:14
The Pharma Data
DECEMBER 6, 2022
Novartis Pluvicto™ shows statistically significant and clinically meaningful radiographic progression-free survival benefit in patients with PSMA–positive metastatic castration-resistant prostate cancer.
Pharma Phorum
DECEMBER 4, 2022
Contrary to Big Tech, historically the pharmaceutical industry has had a good reputation for being a female-positive industry. However, both industries share a common problem: failure to provide women with C-suite opportunities.
Drug Channels
DECEMBER 6, 2022
In Preferred Pharmacy Networks in 2023’s Medicare Part D Plans: Cigna, CVS Health, Humana, UnitedHealthcare, WellCare, and More , I highlighted how those networks have taken over the world of stand-alone Medicare Part D prescription drug plans (PDP) and become a major presence in Medicare Advantage prescription drug (MA-PD) plans.
Bio Pharma Dive
DECEMBER 2, 2022
The approval gives Rigel, a biotech that’s been around since the mid-1990s, its second marketed medicine and a competitor to Servier’s Tibsovo
Fierce Pharma
DECEMBER 5, 2022
SABCS: Lilly aims Verzenio at broader post-surgery breast cancer nod as Novartis' rival draws near. Will FDA bite? Mon, 12/05/2022 - 15:10
Pharmaceutical Commerce
DECEMBER 7, 2022
Confirms cold chain company’s sustainability commitment.
Pharma Phorum
DECEMBER 5, 2022
Valneva has moved a step closer to its goal of becoming the first company to file for approval of a vaccine against chikungunya virus in the US after reporting new clinical data today.
Eversana Intouch
DECEMBER 7, 2022
Justin Chase, SVP, Media, EVERSANA INTOUCH, was recently interviewed by Endpoints News for an article on how pharmaceutical companies are handling both paid and organic interaction on Twitter in the era of Elon Musk ownership.
Bio Pharma Dive
DECEMBER 2, 2022
The FDA’s decision is a step forward for a type of drugmaking known as “multiplex editing,” which involves editing several genes simultaneously
Fierce Pharma
DECEMBER 5, 2022
AstraZeneca partner FibroGen slaps former employees with trade secret theft lawsuit. zbecker. Mon, 12/05/2022 - 10:31
Pharmaceutical Commerce
DECEMBER 7, 2022
Big Pharma to collaborate with researchers from A*STAR, along with Singapore universities.
Pharma Phorum
DECEMBER 5, 2022
Harnessing the power of natural killer (NK) cells to attack cancer is as-yet an unproven strategy in oncology – but one that is garnering increased interest as clinical trials start to generate data.
The FDA Law Blog
DECEMBER 7, 2022
By Mark A. Tobolowsky & James E.
Bio Pharma Dive
DECEMBER 1, 2022
The drug is currently in mid-stage testing as a treatment for ulcerative colitis. If it continues to advance, it could be the first approved therapy aimed at a protein known as TL1A, a target multiple other companies are pursuing
Fierce Pharma
DECEMBER 1, 2022
PureTech readies oral CBD capsule for clinic to challenge Jazz’s Epidiolex. ntaylor. Thu, 12/01/2022 - 11:05
XTalks
DECEMBER 5, 2022
Clinical-stage biotech company PureTech Health has announced it has developed a new oral CBD therapeutic candidate with improved bioavailability and tolerability, which could expand use of the CBD prodrug in a wide range of indications and age groups.
Pharmaceutical Technology
DECEMBER 5, 2022
Cannabinoid receptors are a popular therapeutic target for cannabinoid-based drugs in the treatment of pain, neurological disorders and inflammation, according to GlobalData’s Pharma Intelligence Centre Drugs database.
BioSpace
DECEMBER 5, 2022
MEI Pharma, Inc. will have a strategic realignment that would see at least 30% of its workforce laid off and a pivot towards two of its earlier clinical-stage assets
244 
Let's personalize your content